Your account has not been permission, data will display ***. Please Upgrade to use. Close notice
Hướng dẫn sử dụng

Vidipha Central Pharmaceutical Joint Stock Company (HOSE: VDP)

40,000

(%)
04/19/2024 15:00

Open38,100

High40,000

Low37,800

Vol600

Market Cap.736.12

Remain Bid1,700

Remain Ask2,200

52Wk High41,900

52Wk Low32,900

52Wk Avg Vol1,330

Foreign Buy-

Frgn Owned(%)0.33

Dividend2,500

Dividend Yield0.06

Beta0.42

EPS4,713

P/E8.49

F P/E7.36

BVPS39,711

P/B1.01

Financial ratios of latest trading date, EPS in the company's latest quarter Financial Statement
View with VDP: OPC TRA DHG IMP CTG
Trending: HPG (87,628) - NVL (72,626) - DIG (66,730) - MBB (57,369) - VND (50,146)
1 day | 5 day | 3 months | 6 months | 12 months
- VIDIPHA Central Pharmaceutical Joint Stock Company (VDP) was established in 2003 through equitization of Central Pharmaceutical Technology Development Company. The Company has its core business in production, trading, import and export of pharmaceuticals and medical materials. Vidipha is one of the first pharmaceutical enterprises in Vietnam to meet GMP-ASEAN standards. In the past time, the Company has invested in... View more
DateCloseChangeVolume
04/19/202440,0000 (0.00%)600
04/17/202440,000-1,000 (-2.44%)1,300
04/16/202441,0001,900 (+4.86%)2,000
04/15/202439,1000 (0.00%)100
04/12/202439,1000 (0.00%)100
Volume: share, Price: Dong
Unit: Million Dong
Unit: Million Dong
03/08/2024VDP Dividend payment in cash with 15.00% (Tranche 2/2023) (Record date)
03/08/2024VDP Dividend payment in cash with 15.00% (Tranche 2/2023)
12/22/2023VDP Dividend payment in cash with 10.00% (Tranche 1/2023) (Record date)
12/22/2023VDP Dividend payment in cash with 10.00% (Tranche 1/2023)
03/14/2023VDP Dividend payment in cash with 15.00% (Tranche 2/2022) (Record date)
04/15/2024Resolution of Annual Shareholders' Meeting 2024
03/25/20242024 Annual Shareholders’Meeting Documents
04/19/2024Annual report 2023
03/29/2024Audited FS 2023
03/07/2024FS Quarter 1 of 2023

Vidipha Central Pharmaceutical Joint Stock Company

Name: Vidipha Central Pharmaceutical Joint Stock Company

Abbreviation:VIDIPHA

Address: 184/2 Le Van Sy Street, Ward 10 Phu Nhuan Ho Chi Minh

Telephone: (84.28) 3844 3869 - 3844 0448 - 3844 0106

Fax: (84.28) 3844 0446

Email:vidipha@hcm.vnn.vn

Website:http://vidipha.com.vn

Exchange: HOSE

Sector: Manufacturing

Industry: Chemical - Pharmaceutical

Listing date: 08/15/2017

Chartered capital: 184,029,040,000

Listed shares: 18,402,904

Shares outstanding: 18,402,904

Status: Operating

Tax code: 0300470246

Establishment license: 0300470246

Issued date: 07/09/1993

Business license: 0300470246

Issued date: 03/24/2003

Main business scope:

- Producing pharmaceuticals, medical materials.

- Trading, importing, exporting pharmaceuticals, medical materials.

- 2003: VIDIPHA Central Pharmaceutical Joint Stock Company was established with the charter capital of VND19.9 billion, in which the State holds 45% stake;

- 2006: Charter capital was raised up to VND50 billion;

- 2007: Charter capital was raised up to VND60 billion;

- 2011: Charter capital was raised up to VND82.86 billion;

- 2013: Charter capital was raised up to VND87 billion;

- 2015: Charter capital was raised up to VND121,74 billion;

- 2016: Charter capital was raised up to VND127,82 billion;

- July 27, 2017: Listed on Ho Chi Minh Stock Exchange (HOSE);

- August 15, 2017: Traded on Ho Chi Minh Stock Exchange (HOSE);

- March 09, 2021: Charter capital was raised up to VND160,495,040,000;

ItemsUnit
PriceVND
VolumeShares
Foreigner's, Yield%
Mkt CapbVND
Financial indicatorsmVND
EPS, BVPS, DividendVND
P/E, F P/E, P/BTimes
ROS, ROA, ROE%
1. The accounting period for the equitization year is defined as of the company's establishment date.
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
* Vietstock tổng hợp thông tin từ các nguồn đáng tin cậy vào thời điểm công bố cho mục đích cung cấp thông tin tham khảo. Vietstock không chịu trách nhiệm đối với bất kỳ kết quả nào từ việc sử dụng các thông tin này.